217 related articles for article (PubMed ID: 9916927)
1. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.
Soravia C; Sugg SL; Berk T; Mitri A; Cheng H; Gallinger S; Cohen Z; Asa SL; Bapat BV
Am J Pathol; 1999 Jan; 154(1):127-35. PubMed ID: 9916927
[TBL] [Abstract][Full Text] [Related]
2. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A
J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763
[TBL] [Abstract][Full Text] [Related]
3. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
[TBL] [Abstract][Full Text] [Related]
4. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in
Nieminen TT; Walker CJ; Olkinuora A; Genutis LK; O'Malley M; Wakely PE; LaGuardia L; Koskenvuo L; Arola J; Lepistö AH; Brock P; Yilmaz AS; Eisfeld AK; Church JM; Peltomäki P; de la Chapelle A
Thyroid; 2020 Mar; 30(3):380-388. PubMed ID: 32024448
[No Abstract] [Full Text] [Related]
7. Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms.
Giannelli SM; McPhaul L; Nakamoto J; Gianoukakis AG
Thyroid; 2014 Jul; 24(7):1184-9. PubMed ID: 24702198
[TBL] [Abstract][Full Text] [Related]
8. Thyroid carcinoma associated with familial adenomatous polyposis.
Cetta F; Toti P; Petracci M; Montalto G; Disanto A; Lorè F; Fusco A
Histopathology; 1997 Sep; 31(3):231-6. PubMed ID: 9354893
[TBL] [Abstract][Full Text] [Related]
9. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
10. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
[TBL] [Abstract][Full Text] [Related]
11. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.
Cetta F; Olschwang S; Petracci M; Montalto G; Baldi C; Zuckermann M; Mariani Costantini R; Fusco A
World J Surg; 1998 Dec; 22(12):1231-6. PubMed ID: 9841749
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene.
Cetta F; Curia MC; Montalto G; Gori M; Cama A; Battista P; Barbarisi A
J Clin Endocrinol Metab; 2001 Jan; 86(1):427-32. PubMed ID: 11232035
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
Cheung CC; Carydis B; Ezzat S; Bedard YC; Asa SL
J Clin Endocrinol Metab; 2001 May; 86(5):2187-90. PubMed ID: 11344225
[TBL] [Abstract][Full Text] [Related]
16. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics.
Cheung CC; Boerner SL; MacMillan CM; Ramyar L; Asa SL
Am J Surg Pathol; 2000 Dec; 24(12):1622-6. PubMed ID: 11117782
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
18. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
19. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
20. RET activation and clinicopathologic features in poorly differentiated thyroid tumors.
Santoro M; Papotti M; Chiappetta G; Garcia-Rostan G; Volante M; Johnson C; Camp RL; Pentimalli F; Monaco C; Herrero A; Carcangiu ML; Fusco A; Tallini G
J Clin Endocrinol Metab; 2002 Jan; 87(1):370-9. PubMed ID: 11788678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
